logo
logo
logo
logo
Marcel Carroll 2021-04-20
(Florida Atlantic University) Because COVID-19 has been detected in urine and stool samples, public restrooms can be cause for concern. Researchers measured droplets generated from flushing a toilet and a urinal in a public restroom and found a substantial increase in the measured aerosol levels in the ambient environment with the total number of droplets generated in each flushing test ranging up to the tens of thousands. Due to their small size, these droplets can remain suspended for a long time.
collect
0
Robert Flenard 2020-09-27
img

Viruses jumping from animals to humans have been the starting point of numerous outbreaks, from Ebola to Zika. Given the similarity of SARS-CoV-2 to coronaviruses found in bats, this probably marked the beginning of COVID-19 too. We know that viruses have passed from animals to humans throughout history, and will continue to do so. But the factors that influence the geographical origin of these events is less clear, despite being highly important. Knowing where they occur can help us understand the factors behind a virus crossing species, in particular, by looking at the traits of viruses circulating in the ecosystem…

This story continues at The Next Web
collect
0
David Clary 2021-03-12
img
Ebola virus is known to persist in some survivors—but not for this long.
collect
0
Jerrod Fenton 2021-05-26
Illustration by Alex Castro / The Verge

Facebook won’t remove claims that COVID-19 was man-made anymore, according to a report from Politico that cites a Facebook spokesperson. The company altered its policy because of a renewed focus on the origins of the virus, including an order from President Joe Biden to his intelligence agencies to investigate the so-called lab-leak hypothesis.

Facebook’s policy change was made “in consultation with public health experts,” that spokesperson told Politico. The social network’s policy mandates that false claims and conspiracy theories about the virus be removed.

Misinformation has often circulated on Facebook, including during the Ebola crisis in 2014. The company is under...

Continue reading…

collect
0
Alan Krieg 2020-12-24
img
Dr. Lana Dbeibo breaks down how the vaccine was developed so quickly and shares her thoughts on its potential long-term side effects.
collect
0
Ronnie Allen 2020-12-21
img
(University of Texas at Austin, Texas Advanced Computing Center) Computer simulations of the Ebola virus structure are helping to crack its defenses. Ebola virus nucleocapsid stability conferred by RNA electrostatic interactions. XSEDE EMPOWER undergraduate program, allocations on TACC Stampede2 and PSC Bridges systems supported research. Research by Perilla Lab of the University of Delaware opens door for possible druggable sites targeting stability of Ebola virus nucleocapsid.
collect
0
Cornelius Jones 2021-06-30
img
Harvard and MIT researchers teamed up to develop a face mask capable of detecting if the wearer is infected with SARS-CoV-2, the virus that causes COVID-19. It only takes about 90 minutes for the mask to detect the virus, according to the newly published study on the innovation. The same tech could also potentially be leveraged to detect other types … Continue reading
collect
0
Pavan Ishi 2021-05-07

Viral infections and pandemics have been exerting a significant economic cost burden on health care systems around the world.

Despite development of new treatment paradigms for viral infections, infections such as the human immunodeficiency virus (HIV) and hepatitis have been responsible for numerous deaths globally.

There has been a gradual shift toward new techniques and methods of diagnosis of viral infections, including nucleic acid amplification test (NAAT), which have shown promising results with improved accuracy and reduced time of diagnosis.

Moreover, outbreak of new viral infections in the recent past such as Ebola, hemorrhagic fever, and swine influenza a virus is driving demand for new and innovative virus diagnostic test kits across the world.

However, high price of new test kits is a major restraining factor for the adoption of these kits in emerging countries, which are currently relying on traditional and time consuming test kits for virus detection.The global virus diagnostic test kits market can be segmented based on type, test, end- user, and region.

In terms of test, the global virus diagnostic test kits market can be categorized into traditional tests (cell culture test, complement fixation test (CFT), Haemagglutination inhibition test, and others) and rapid tests (nucleic acid amplification test (NAAT), immunoassay test, next generation sequencing (NGS), and mass spectrometry).

collect
0
Pavan Ishi 2021-05-03

Viral infections and pandemics have been exerting a significant economic cost burden on health care systems around the world.

Despite development of new treatment paradigms for viral infections, infections such as the human immunodeficiency virus (HIV) and hepatitis have been responsible for numerous deaths globally.

There has been a gradual shift toward new techniques and methods of diagnosis of viral infections, including nucleic acid amplification test (NAAT), which have shown promising results with improved accuracy and reduced time of diagnosis.

Moreover, outbreak of new viral infections in the recent past such as Ebola, hemorrhagic fever, and swine influenza a virus is driving demand for new and innovative virus diagnostic test kits across the world.

However, high price of new test kits is a major restraining factor for the adoption of these kits in emerging countries, which are currently relying on traditional and time consuming test kits for virus detection.The global virus diagnostic test kits market can be segmented based on type, test, end- user, and region.

In terms of test, the global virus diagnostic test kits market can be categorized into traditional tests (cell culture test, complement fixation test (CFT), Haemagglutination inhibition test, and others) and rapid tests (nucleic acid amplification test (NAAT), immunoassay test, next generation sequencing (NGS), and mass spectrometry).

collect
0
Pavan Ishi 2020-11-17

Viral infections and pandemics have been exerting a significant economic cost burden on health care systems around the world.

Despite development of new treatment paradigms for viral infections, infections such as the human immunodeficiency virus (HIV) and hepatitis have been responsible for numerous deaths globally.

There has been a gradual shift toward new techniques and methods of diagnosis of viral infections, including nucleic acid amplification test (NAAT), which have shown promising results with improved accuracy and reduced time of diagnosis.

This has led to the development of new and advanced viral diagnostic test kits.Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=46338Rise in incidence of viral infections such as hepatitis, respiratory syncytial virus, and human immunodeficiency virus (HIV) worldwide is expected to boost the viral diagnostic test kits market.

Moreover, outbreak of new viral infections in the recent past such as Ebola, hemorrhagic fever, and swine influenza a virus is driving demand for new and innovative virus diagnostic test kits across the world.

However, high price of new test kits is a major restraining factor for the adoption of these kits in emerging countries, which are currently relying on traditional and time consuming test kits for virus detection.The global virus diagnostic test kits market can be segmented based on type, test, end- user, and region.

collect
0
Christopher Hardy 2021-02-09
(American Institute of Physics) Advances in the fields of biomaterials and nanotechnology could lead to big breakthroughs in the fight against dangerous viruses like the novel coronavirus that causes COVID-19. In APL Bioengineering, researchers from the Indian Institute of Science describe possibilities being explored by scientists, combining biomaterials and nanotechnology, to make vaccines more effective and build surfaces that could fight and kill viruses on their own.
collect
0
William Hill 2020-08-22
img
Earlier this summer, public health officials warned that new cases of Ebola had appeared in the Democratic Republic of the Congo, indicating that another outbreak was underway. Only around five weeks later, the number of cases nearly doubled to 100, marking the 11th outbreak in the DRC. Whereas the new outbreak was originally declared in the Equateur Province’s capital city, … Continue reading
collect
0
Victor Mcbride 2021-05-14
img
The coronavirus' origin remains a mystery. So the idea that it was accidentally released from a lab remains viable, according to 18 scientists.
collect
0
Robbie Kromer 2021-06-28
img
Some experts now think it's a good idea to get an mRNA booster shot after a dose of the AstraZeneca or Johnson & Johnson vaccines.
collect
0
Gmi Research 2021-08-17
img

Global Ebola Vaccine Market The GMI Research expects the Ebola Vaccine Market to notice an augmentation in demand over the forecast period.

This is mainly due to the increased mortality rate, lack of efficient treatments, rising concentration on research activities to launch effective medicines, and favorable government norms.Request a FREE Sample of Ebola Vaccine Market.Introduction of the Ebola Vaccine Market Ebola Vaccine or Ebola hemorrhagic fever (EHF) are vaccines either accepted or in the development phase to reduce the chances of Ebola resulting from the Ebola virus.

Besides this, it leads to the hemorrhagic fever that causes internal or external bleeding.Ebola Vaccine MarketKey Players of Market:Mapp Biopharmaceutical Inc.Merck & Company, Inc.Novavax Inc.Sarepta Therapeutics Inc.Regeneron PharmaceuticalsGlaxoSmithKline plc.GeoVax Labs Inc., LtdEbola Vaccine Market DynamicsThe comprehensive research and development activities to introduce a streamlined and robust solution for Ebola disease is a  factor proliferating the opportunities in the Ebola Vaccine Market.

For example, key players such as Serepata Therapeutics, NewLink Genetics Tekmira Pharmaceuticals, and Mapp Biopharmaceutical are stressing research activities to establish Ebola Vaccine.

On the other hand, insufficient reconciliation policies in emerging countries and inadequate consciousness will restrain the Ebola virus Vaccine market size.Virus strain Segment DriversIn accordance with the Virus strain, Chimpanzee adenovirus type 3-Zaire Ebola virus is projected to witness faster growth over the forecast period.

Moreover, according to the Ebola market research reports, aggravating R activities for anti-Ebola products are likely to propel market growth.Regional DriversOn the basis of regional coverage, North America is contemplated to dominate the market during the coming years.

collect
0
James Farr 2020-10-22
img
Gilead Sciences just received approval from the US Food and Drug Administration to use its antiviral remdesivir drug for COVID-19 treatment.
collect
0
Marcel Carroll 2021-04-20
(Florida Atlantic University) Because COVID-19 has been detected in urine and stool samples, public restrooms can be cause for concern. Researchers measured droplets generated from flushing a toilet and a urinal in a public restroom and found a substantial increase in the measured aerosol levels in the ambient environment with the total number of droplets generated in each flushing test ranging up to the tens of thousands. Due to their small size, these droplets can remain suspended for a long time.
David Clary 2021-03-12
img
Ebola virus is known to persist in some survivors—but not for this long.
Alan Krieg 2020-12-24
img
Dr. Lana Dbeibo breaks down how the vaccine was developed so quickly and shares her thoughts on its potential long-term side effects.
Cornelius Jones 2021-06-30
img
Harvard and MIT researchers teamed up to develop a face mask capable of detecting if the wearer is infected with SARS-CoV-2, the virus that causes COVID-19. It only takes about 90 minutes for the mask to detect the virus, according to the newly published study on the innovation. The same tech could also potentially be leveraged to detect other types … Continue reading
Pavan Ishi 2021-05-03

Viral infections and pandemics have been exerting a significant economic cost burden on health care systems around the world.

Despite development of new treatment paradigms for viral infections, infections such as the human immunodeficiency virus (HIV) and hepatitis have been responsible for numerous deaths globally.

There has been a gradual shift toward new techniques and methods of diagnosis of viral infections, including nucleic acid amplification test (NAAT), which have shown promising results with improved accuracy and reduced time of diagnosis.

Moreover, outbreak of new viral infections in the recent past such as Ebola, hemorrhagic fever, and swine influenza a virus is driving demand for new and innovative virus diagnostic test kits across the world.

However, high price of new test kits is a major restraining factor for the adoption of these kits in emerging countries, which are currently relying on traditional and time consuming test kits for virus detection.The global virus diagnostic test kits market can be segmented based on type, test, end- user, and region.

In terms of test, the global virus diagnostic test kits market can be categorized into traditional tests (cell culture test, complement fixation test (CFT), Haemagglutination inhibition test, and others) and rapid tests (nucleic acid amplification test (NAAT), immunoassay test, next generation sequencing (NGS), and mass spectrometry).

Christopher Hardy 2021-02-09
(American Institute of Physics) Advances in the fields of biomaterials and nanotechnology could lead to big breakthroughs in the fight against dangerous viruses like the novel coronavirus that causes COVID-19. In APL Bioengineering, researchers from the Indian Institute of Science describe possibilities being explored by scientists, combining biomaterials and nanotechnology, to make vaccines more effective and build surfaces that could fight and kill viruses on their own.
Victor Mcbride 2021-05-14
img
The coronavirus' origin remains a mystery. So the idea that it was accidentally released from a lab remains viable, according to 18 scientists.
Gmi Research 2021-08-17
img

Global Ebola Vaccine Market The GMI Research expects the Ebola Vaccine Market to notice an augmentation in demand over the forecast period.

This is mainly due to the increased mortality rate, lack of efficient treatments, rising concentration on research activities to launch effective medicines, and favorable government norms.Request a FREE Sample of Ebola Vaccine Market.Introduction of the Ebola Vaccine Market Ebola Vaccine or Ebola hemorrhagic fever (EHF) are vaccines either accepted or in the development phase to reduce the chances of Ebola resulting from the Ebola virus.

Besides this, it leads to the hemorrhagic fever that causes internal or external bleeding.Ebola Vaccine MarketKey Players of Market:Mapp Biopharmaceutical Inc.Merck & Company, Inc.Novavax Inc.Sarepta Therapeutics Inc.Regeneron PharmaceuticalsGlaxoSmithKline plc.GeoVax Labs Inc., LtdEbola Vaccine Market DynamicsThe comprehensive research and development activities to introduce a streamlined and robust solution for Ebola disease is a  factor proliferating the opportunities in the Ebola Vaccine Market.

For example, key players such as Serepata Therapeutics, NewLink Genetics Tekmira Pharmaceuticals, and Mapp Biopharmaceutical are stressing research activities to establish Ebola Vaccine.

On the other hand, insufficient reconciliation policies in emerging countries and inadequate consciousness will restrain the Ebola virus Vaccine market size.Virus strain Segment DriversIn accordance with the Virus strain, Chimpanzee adenovirus type 3-Zaire Ebola virus is projected to witness faster growth over the forecast period.

Moreover, according to the Ebola market research reports, aggravating R activities for anti-Ebola products are likely to propel market growth.Regional DriversOn the basis of regional coverage, North America is contemplated to dominate the market during the coming years.

Robert Flenard 2020-09-27
img

Viruses jumping from animals to humans have been the starting point of numerous outbreaks, from Ebola to Zika. Given the similarity of SARS-CoV-2 to coronaviruses found in bats, this probably marked the beginning of COVID-19 too. We know that viruses have passed from animals to humans throughout history, and will continue to do so. But the factors that influence the geographical origin of these events is less clear, despite being highly important. Knowing where they occur can help us understand the factors behind a virus crossing species, in particular, by looking at the traits of viruses circulating in the ecosystem…

This story continues at The Next Web
Jerrod Fenton 2021-05-26
Illustration by Alex Castro / The Verge

Facebook won’t remove claims that COVID-19 was man-made anymore, according to a report from Politico that cites a Facebook spokesperson. The company altered its policy because of a renewed focus on the origins of the virus, including an order from President Joe Biden to his intelligence agencies to investigate the so-called lab-leak hypothesis.

Facebook’s policy change was made “in consultation with public health experts,” that spokesperson told Politico. The social network’s policy mandates that false claims and conspiracy theories about the virus be removed.

Misinformation has often circulated on Facebook, including during the Ebola crisis in 2014. The company is under...

Continue reading…

Ronnie Allen 2020-12-21
img
(University of Texas at Austin, Texas Advanced Computing Center) Computer simulations of the Ebola virus structure are helping to crack its defenses. Ebola virus nucleocapsid stability conferred by RNA electrostatic interactions. XSEDE EMPOWER undergraduate program, allocations on TACC Stampede2 and PSC Bridges systems supported research. Research by Perilla Lab of the University of Delaware opens door for possible druggable sites targeting stability of Ebola virus nucleocapsid.
Pavan Ishi 2021-05-07

Viral infections and pandemics have been exerting a significant economic cost burden on health care systems around the world.

Despite development of new treatment paradigms for viral infections, infections such as the human immunodeficiency virus (HIV) and hepatitis have been responsible for numerous deaths globally.

There has been a gradual shift toward new techniques and methods of diagnosis of viral infections, including nucleic acid amplification test (NAAT), which have shown promising results with improved accuracy and reduced time of diagnosis.

Moreover, outbreak of new viral infections in the recent past such as Ebola, hemorrhagic fever, and swine influenza a virus is driving demand for new and innovative virus diagnostic test kits across the world.

However, high price of new test kits is a major restraining factor for the adoption of these kits in emerging countries, which are currently relying on traditional and time consuming test kits for virus detection.The global virus diagnostic test kits market can be segmented based on type, test, end- user, and region.

In terms of test, the global virus diagnostic test kits market can be categorized into traditional tests (cell culture test, complement fixation test (CFT), Haemagglutination inhibition test, and others) and rapid tests (nucleic acid amplification test (NAAT), immunoassay test, next generation sequencing (NGS), and mass spectrometry).

Pavan Ishi 2020-11-17

Viral infections and pandemics have been exerting a significant economic cost burden on health care systems around the world.

Despite development of new treatment paradigms for viral infections, infections such as the human immunodeficiency virus (HIV) and hepatitis have been responsible for numerous deaths globally.

There has been a gradual shift toward new techniques and methods of diagnosis of viral infections, including nucleic acid amplification test (NAAT), which have shown promising results with improved accuracy and reduced time of diagnosis.

This has led to the development of new and advanced viral diagnostic test kits.Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=46338Rise in incidence of viral infections such as hepatitis, respiratory syncytial virus, and human immunodeficiency virus (HIV) worldwide is expected to boost the viral diagnostic test kits market.

Moreover, outbreak of new viral infections in the recent past such as Ebola, hemorrhagic fever, and swine influenza a virus is driving demand for new and innovative virus diagnostic test kits across the world.

However, high price of new test kits is a major restraining factor for the adoption of these kits in emerging countries, which are currently relying on traditional and time consuming test kits for virus detection.The global virus diagnostic test kits market can be segmented based on type, test, end- user, and region.

William Hill 2020-08-22
img
Earlier this summer, public health officials warned that new cases of Ebola had appeared in the Democratic Republic of the Congo, indicating that another outbreak was underway. Only around five weeks later, the number of cases nearly doubled to 100, marking the 11th outbreak in the DRC. Whereas the new outbreak was originally declared in the Equateur Province’s capital city, … Continue reading
Robbie Kromer 2021-06-28
img
Some experts now think it's a good idea to get an mRNA booster shot after a dose of the AstraZeneca or Johnson & Johnson vaccines.
James Farr 2020-10-22
img
Gilead Sciences just received approval from the US Food and Drug Administration to use its antiviral remdesivir drug for COVID-19 treatment.